Ferdinand M. Wit

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 117 publications

Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND.

Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND.

Journal: Open forum infectious diseases

Published: March 19, 2026

CD4+ cell count trends after common cancers in people with HIV: a multicohort collaboration.

CD4+ cell count trends after common cancers in people with HIV: a multicohort collaboration.

Journal: AIDS (London, England)

Published: November 13, 2025

Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration.

Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration.

Journal: Cancers

Published: October 31, 2025

Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations.

Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations.

Journal: EClinicalMedicine

Published: September 02, 2025

Incidence of Community-acquired Pneumonia and Herpes Zoster in People With HIV Based on CD4 Count and Age in the Current Antiretroviral Therapy Era: A Longitudinal Cohort Study.

Incidence of Community-acquired Pneumonia and Herpes Zoster in People With HIV Based on CD4 Count and Age in the Current Antiretroviral Therapy Era: A Longitudinal Cohort Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 31, 2025

Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk.

Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 18, 2025

Labor Market Outcomes of People with HIV Pre- and Post-Diagnosis in the Netherlands.

Labor Market Outcomes of People with HIV Pre- and Post-Diagnosis in the Netherlands.

Journal: Nature communications

Published: April 24, 2025

Use of Preventive Measures for Cardiovascular Disease in People With HIV.

Use of Preventive Measures for Cardiovascular Disease in People With HIV.

Journal: Open forum infectious diseases

Published: March 10, 2025

Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study.

Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study.

Journal: EClinicalMedicine

Published: February 28, 2025

Risk of Cancer in People With HIV Experiencing Varying Degrees of Immune Recovery With Sustained Virological Suppression on Antiretroviral Treatment for More Than 2 Years: An International, Multicenter, Observational Cohort.

Risk of Cancer in People With HIV Experiencing Varying Degrees of Immune Recovery With Sustained Virological Suppression on Antiretroviral Treatment for More Than 2 Years: An International, Multicenter, Observational Cohort.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 24, 2025

Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process.

Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process.

Journal: The lancet. HIV

Published: January 08, 2025

Longitudinal plasma proteomic signatures of elite and viremic spontaneous HIV controllers.

Longitudinal plasma proteomic signatures of elite and viremic spontaneous HIV controllers.

Journal: Nature communications

Published: December 28, 2024

Showing 1-12 of 117

Last Updated: 09/26/2026